D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$939M |
| 2 |
Netflix
NFLX
|
+$838M |
| 3 |
Micron Technology
MU
|
+$490M |
| 4 |
Affirm
AFRM
|
+$417M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$399M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$356M |
| 5 |
UnitedHealth
UNH
|
+$299M |
Sector Composition
| 1 | Technology | 28.8% |
| 2 | Consumer Discretionary | 15.68% |
| 3 | Healthcare | 9.51% |
| 4 | Financials | 8.37% |
| 5 | Communication Services | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Varex Imaging
VREX
$469M
| $3.72M | ﹤0.01% |
181,672
-128,366
| -41% | -$2.63M |
|
1252
Arcellx
ACLX
$4.23B
| $3.72M | ﹤0.01% |
+67,074
| New | +$3.72M |
|
1253
Interparfums
IPAR
$3.43B
| $3.7M | ﹤0.01% |
+25,712
| New | +$3.7M |
|
1254
Phreesia
PHR
$1.45B
| $3.7M | ﹤0.01% |
159,631
-183,098
| -53% | -$4.24M |
|
|
CNSL
1255
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $3.69M | ﹤0.01% |
847,959
+173,705
| +26% | +$756K |
|
1256
CSX Corp
CSX
$60.5B
| $3.69M | ﹤0.01% |
106,289
+99,459
| +1,456% | +$3.45M |
|
|
PRSU
1257
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.04B
| $3.68M | ﹤0.01% |
101,714
+5,475
| +6% | +$198K |
|
1258
Guardant Health
GH
$6.85B
| $3.68M | ﹤0.01% |
136,029
-90,063
| -40% | -$2.44M |
|
1259
Clearwater Paper
CLW
$344M
| $3.68M | ﹤0.01% |
101,807
+51,066
| +101% | +$1.84M |
|
1260
Kodiak Sciences
KOD
$489M
| $3.68M | ﹤0.01% |
1,208,973
+212,840
| +21% | +$647K |
|
1261
Vanguard Total Stock Market ETF
VTI
$536B
| $3.67M | ﹤0.01% |
+15,469
| New | +$3.67M |
|
1262
Zions Bancorporation
ZION
$8.62B
| $3.67M | ﹤0.01% |
83,616
+69,556
| +495% | +$3.05M |
|
1263
Cummins
CMI
$56.5B
| $3.65M | ﹤0.01% |
15,245
+3,069
| +25% | +$735K |
|
1264
Antero Midstream
AM
$8.91B
| $3.65M | ﹤0.01% |
291,343
+43,182
| +17% | +$541K |
|
1265
Vericel Corp
VCEL
$1.62B
| $3.65M | ﹤0.01% |
102,439
-76,750
| -43% | -$2.73M |
|
1266
SAP
SAP
$299B
| $3.64M | ﹤0.01% |
+23,551
| New | +$3.64M |
|
1267
Toyota
TM
$256B
| $3.64M | ﹤0.01% |
+19,844
| New | +$3.64M |
|
1268
Olin
OLN
$3.02B
| $3.63M | ﹤0.01% |
67,276
-16,400
| -20% | -$885K |
|
1269
Esperion Therapeutics
ESPR
$573M
| $3.63M | ﹤0.01% |
+1,213,203
| New | +$3.63M |
|
1270
W.R. Berkley
WRB
$28B
| $3.63M | ﹤0.01% |
76,893
-270,752
| -78% | -$12.8M |
|
|
RVNC
1271
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.62M | ﹤0.01% |
411,750
-370,266
| -47% | -$3.25M |
|
1272
Madrigal Pharmaceuticals
MDGL
$9.63B
| $3.61M | ﹤0.01% |
15,622
+9,708
| +164% | +$2.25M |
|
1273
Microvast
MVST
$1.06B
| $3.61M | ﹤0.01% |
2,580,479
+428,093
| +20% | +$599K |
|
1274
Gevo
GEVO
$404M
| $3.61M | ﹤0.01% |
3,107,884
-230,299
| -7% | -$267K |
|
1275
Alto Ingredients
ALTO
$91.3M
| $3.6M | ﹤0.01% |
1,354,886
+497,854
| +58% | +$1.32M |
|